Researchers from Eindhoven University of Technology (TU/e) and Keio University today present a practicable and reliable way to test for infectious diseases.
All you need are a special glowing paper strip, a drop of blood and a digital camera, as they write in the scientific journal Angewandte Chemie. Not only does this make the technology very cheap and fast – after twenty minutes it is clear whether there is an infection – it also makes expensive and time-consuming laboratory measurements in the hospital unnecessary. In addition, the test has a lot of potential in developing countries for the easy testing of tropical diseases.
The test shows the presence of infectious diseases by searching for certain antibodies in the blood that your body makes in response to, for example, viruses and bacteria. The development of handy tests for the detection of antibodies is in the spotlight as a practicable and quick alternative to expensive, time-consuming laboratory measurements in hospitals. Doctors are also increasingly using antibodies as medicines, for example in the case of cancer or rheumatism. So this simple test is also suitable for regularly monitoring the dose of such medicines to be able to take corrective measures in good time.
The use of the paper strip developed by the Dutch and Japanese researchers is a piece of cake. Apply a drop of blood to the appropriate place on the paper, wait twenty minutes and turn it over. “A biochemical reaction causes the underside of paper to emit blue-green light,” says Eindhoven University of Technology professor and research leader Maarten Merkx. “The bluer the color, the higher the concentration of antibodies.” A digital camera, for example from a mobile phone, is sufficient to determine the exact color and thus the result.
The color is created thanks to the secret ingredient of the paper strip: a so-called luminous sensor protein developed at TU/e. After a droplet of blood comes onto the paper, this protein triggers a reaction in which blue light is produced (known as bioluminescence). An enzyme that also illuminates fireflies and certain fish, for example, plays a role in this. In a second step, the blue light is converted into green light. But here comes the clue: if an antibody binds to the sensor protein, it blocks the second step. A lot of green means few antibodies and, vice versa, less green means more antibodies.
The ratio of blue and green light can be used to derive the concentration of antibodies. “So not only do you know whether the antibody is in the blood, but also how much,” says Merkx. By measuring the ratio precisely, they suffer less from problems that other biosensors often have, such as the signal becoming weaker over time. In their prototype, they successfully tested three antibodies simultaneously, for HIV, flu and dengue fever. Merkx expects the test to be commercially available within a few years.
The Latest on: Test for infectious diseases
via Google News
The Latest on: Test for infectious diseases
- Helix moves a step closer to goal of 100,000 daily COVID-19 tests at San Diego labon August 10, 2020 at 5:43 pm
Helix has cleared a hurdle in its bid to process up to 100,000 COVID-19 tests per day at its San Diego lab by the fall, which would make it one of the highest volume pandemic testing sites in the ...
- Antonio Banderas reveals positive COVID-19 test results on his 60th birthdayon August 10, 2020 at 5:09 pm
"I want to make it public that today, Aug. 10, I am forced to celebrate my 60th birthday in quarantine, having tested positive for the COVID-19 disease, caused by the ... I hope will allow me to ...
- Antonio Banderas tests positive for coronavirus on 60th birthdayon August 10, 2020 at 3:08 pm
Pain and Glory” star Antonio Banderas revealed he has tested positive for COVID-19 on Monday, his 60th birthday.
- Antonio Banderas tests positive for coronavirus, shares results on 60th birthdayon August 10, 2020 at 3:06 pm
The Spanish actor shared his positive test results on his 60th birthday and said that celebrations would have to wait until after quarantine.
- Super spreaders drive COVID-19: 80% of those infected likely don’t spread disease, Fred Hutch study findson August 10, 2020 at 10:53 am
About 80% of people infected with the novel coronavirus don’t spread the infection to anyone else, leaving the so-called super spreaders as the drivers of the global pandemic that has infected ...
- AbbVie infectious disease exec jumps ship to COVID antiviral biotechon August 10, 2020 at 8:28 am
AbbVie and Roche alum Janet Hammond, M.D., Ph.D., Sc.M., F.C.P. has nabbed the chief development officer role at infectious disease biotech Atea Pharmaceuticals.
- Trump calls Birx's COVID-19 warnings pathetic — but the real test is what she does nexton August 10, 2020 at 1:34 am
Doctors like Fauci and Birx find themselves in an unenviable position, as do so many employed by the Trump administration. But given our national crisis, there is little room for excuses.
- Brigham's infectious diseases chief on slow increase of Mass. COVID-19 caseson August 5, 2020 at 3:03 pm
Dr. Daniel Kuritzkes, chief of the division of infectious diseases at Brigham and Women's Hospital, also explains why its so important for COVID-19 testing to come back as rapidly as possible.
- When is the right time to test for COVID-19? Infectious disease specialist explainson August 5, 2020 at 7:46 am
FIU epidemiologist and infectious disease specialist Dr. Aileen Marty joins Bob Sirott to talk about a new study on COVID-19 testing, when is the right time to get tested if exposed to someone ...
via Bing News